IAM
TMO icon

Integre Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Integre Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4.33M Sell
13,312
-745
-5% -$226K 2.45% 13
2019
Q3 		$4.09M Sell
14,057
-2,709
-16% -$776K 2.44% 13
2019
Q2 		$4.92M Sell
16,766
-289
-2% -$79.6K 2.82% 6
2019
Q1 		$4.67M Buy
17,055
+521
+3% +$130K 2.82% 8
2018
Q4 		$3.7M Sell
16,534
-863
-5% -$202K 2.62% 9
2018
Q3 		$4.25M Sell
17,397
-109
-0.6% -$25.1K 2.46% 13
2018
Q2 		$3.63M Sell
17,506
-87
-0.5% -$18.5K 2.32% 13
2018
Q1 		$3.63M Sell
17,593
-1,005
-5% -$211K 2.38% 14
2017
Q4 		$3.53M Buy
18,598
+379
+2% +$72.6K 2.09% 16
2017
Q3 		$3.45M Sell
18,219
-4,713
-21% -$854K 2.3% 12
2017
Q2 		$4M Sell
22,932
-685
-3% -$115K 2.43% 13
2017
Q1 		$3.63M Sell
23,617
-509
-2% -$77.8K 2.12% 17
2016
Q4 		$3.4M Sell
24,126
-3,804
-14% -$561K 1.1% 38
2016
Q3 		$4.44M Buy
+27,930
New +$4.3M 1.38% 27

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Integre Asset Management's TMO Position: Q4 2019 in Review

Integre Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 5.3% in Q4 2019, selling an estimated $226K and leaving 13,312 shares worth $4.33M. The position accounts for 2.45% of the portfolio, ranked #13.

Integre Asset Management first reported a position in TMO in Q3 2016 and has held it in 14 quarters since. The position peaked at $4.92M in Q2 2019. 1,678 funds tracked by Wall St. Rank hold TMO as of Q4 2019.

  • Integre Asset Management held 13,312 shares of Thermo Fisher Scientific worth $4.33M as of Q4 2019.
  • Integre Asset Management sold 745 Thermo Fisher Scientific shares in Q4 2019, an estimated $226K.
  • Thermo Fisher Scientific made up 2.45% of Integre Asset Management's portfolio in Q4 2019, its #13 holding.
  • Integre Asset Management first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 14 quarters since.
  • Integre Asset Management's Thermo Fisher Scientific position peaked at $4.92M in Q2 2019.
  • 1,678 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2019.

Based on Integre Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.